51. Recalls that significant historical reasons motivated the seat of the Parliament to be established and that the question of determination of the seat of an Union institution is the exclusive competence of the Member States; notes in this respect that any decision to change the seat arrangement of Parliament would require a change of the Treaties, a decision which would have to be taken unanimously by the Member States;

In 1997 the ECJ ruled (C-345/95) that the right of MS to determine the seat implies that they can also fix the number of plenary sessions to be held in Strasbourg.

Specific activities shall include: understanding the determinants of health (including nutrition, physical activity and gender, and environmental, socio-economic, occupational and climate-related factors); improving health promotion and disease prevention; understanding disease and improving diagnosis and prognosis; developing effective prevention and screening programmes and improving the assessment of disease susceptibility; improving the surveillance of infectious diseases and preparedness for combating epidemics and emerging diseases; developing new and better preventive and therapeutic vaccines and drugs; using in-silico medicine for improving disease management and prediction; developing regenerative medicine and adapted treatm ...[+++]ents, and treating disease, including palliative medicine; transferring knowledge to clinical practice and scalable innovation actions; improving health information and better collection and use of health cohort and administrative data; standardised data analysis and techniques; active ageing, and independent and assisted living; individual awareness and empowerment for self-management of health; promotion of integrated care, including psychosocial aspects; improving scientific tools and methods to support policy making and regulatory needs; optimising the efficiency and effectiveness of healthcare provision; and reducing health disparities and inequalities by evidence-based decision making and dissemination of best practice and by innovative technologies and approaches.

As diagnosis of rare diseases is the first difficulty met by patients, a clinical examination would enable to determine also the suspicion of rare diseases and then should open the possibility for such cases to have access to cross border healthcare and reimbursement even if the treatment methods are not among the benefits provided by the Member State of affiliation.

In order to determine that seat, the court shall apply its rules of private international law.

We remain committed to eradicating the disease, an objective that will be beneficial for both the environment and the salmon-farming sector.